Clinical Trial Update: A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated cysteamine therapy in humans with non-alcoholic steatohepatitis (fatty liver). The trial is completed with results posted on 2014-01…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Cysteamine (cysteamine)

Snippet

Sponsor: Joel Lavine | Conditions: Fatty Liver | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-01-31